Literature DB >> 22487524

Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas.

Noritoshi Kobayashi1, Kazuya Sugimori, Takeshi Shimamura, Kunihiro Hosono, Seitaro Watanabe, Shingo Kato, Michio Ueda, Itaru Endo, Yoshiaki Inayama, Shin Maeda, Atsushi Nakajima, Kensuke Kubota.   

Abstract

BACKGROUND: The preoperative diagnosis of branch duct intraductal papillary mucinous neoplasm (IPMN) of the pancreas can be very difficult, since low-risk and high-risk lesions can be difficult to differentiate even after cytological analysis. The purpose of this study was to evaluate the preoperative diagnostic value of endoscopic ultrasonography (EUS) in differentiating low-risk and high-risk IPMNs.
METHODS: We retrospectively identified 36 patients who underwent preoperative EUS for branch duct IPMNs. The pathological diagnosis after surgical resection was low-grade dysplasia (n = 26), moderate dysplasia (n = 1), high-grade dysplasia or carcinoma in situ (n = 5), and invasive carcinoma (n = 4). We divided the patients into two groups: low risk (low-grade dysplasia or moderate dysplasia) and high risk (high-grade dysplasia or carcinoma). We focused on the diameter of the cystic dilated branch duct, the main pancreatic duct, and the mural nodule as measured using the EUS findings.
RESULTS: The cystic dilated branch duct diameter (31.5 mm vs. 41.9 mm, P = 0.0225) was significantly correlated with low-risk and high-risk IPMNs, but the main pancreatic duct diameter (5.37 mm vs. 5.44 mm, P = 0.9418) was not significantly correlated with the low-risk and high-risk IPMNs. The mural nodule diameter of the papillary protrusions (4.3 mm vs. 16.4 mm, P < 0.0001) and the width diameter of the mural nodule (5.7 mm vs. 23.2 mm, P < 0.0001) were significantly correlated with low-risk and high-risk IPMNs.
CONCLUSIONS: The mural nodule of papillary protrusions diameter and width diameter observed using EUS was a reliable preoperative diagnostic finding capable of distinguishing low-risk and high-risk IPMNs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22487524     DOI: 10.1016/j.pan.2011.12.008

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  12 in total

1.  Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

Review 2.  Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk.

Authors:  Annabelle L Fonseca; Kimberly Kirkwood; Michael P Kim; Anirban Maitra; Eugene J Koay
Journal:  Pancreas       Date:  2018-03       Impact factor: 3.327

Review 3.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

Review 4.  Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms.

Authors:  Alkiviadis Efthymiou; Thrasyvoulos Podas; Emmanouil Zacharakis
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

5.  European evidence-based guidelines on pancreatic cystic neoplasms.

Authors: 
Journal:  Gut       Date:  2018-03-24       Impact factor: 23.059

6.  Contrast-enhanced harmonic endoscopic ultrasonography in pancreatic diseases.

Authors:  Can Xu; Zhaoshen Li; Michael Wallace
Journal:  Diagn Ther Endosc       Date:  2012-11-01

Review 7.  Management of Incidental Pancreatic Cystic Lesions.

Authors:  Christian Jenssen; Stefan Kahl
Journal:  Viszeralmedizin       Date:  2015-02

Review 8.  The utilization of imaging features in the management of intraductal papillary mucinous neoplasms.

Authors:  Stefano Palmucci; Claudia Trombatore; Pietro Valerio Foti; Letizia Antonella Mauro; Pietro Milone; Roberto Milazzotto; Rosalia Latino; Giacomo Bonanno; Giuseppe Petrillo; Antonio Di Cataldo
Journal:  Gastroenterol Res Pract       Date:  2014-08-19       Impact factor: 2.260

9.  A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report.

Authors:  Koichiro Haruki; Shigeki Wakiyama; Yasuro Futagawa; Hiroaki Shiba; Takeyuki Misawa; Katsuhiko Yanaga
Journal:  Surg Case Rep       Date:  2015-02-24

10.  Evaluating the malignant potential of intraductal papillary mucinous neoplasms of the pancreas: added value of non-enhanced endoscopic ultrasound to supplement non-enhanced magnetic resonance imaging.

Authors:  Takao Igarashi; Hirokazu Ashida; Kazuhiko Morikawa; Keitaro Enoki; Kazuyoshi Ohki; Gou Kawakami; Hiroya Ojiri
Journal:  Pol J Radiol       Date:  2018-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.